⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

ALKEM - Technical Analysis with Chart Patterns & Indicators

← Back to List

⭐ Rating: 3.8

Last Updated Time : 19 Sept 26, 02:19 pm

Key Parameters

⭐ Technical Rating: 3.8

RSI53.4
MACD-74.2
DMA 505,375 ₹
DMA 2005,440 ₹
High / Low5,934 ₹
Low price5,051 ₹
High price5,934 ₹
52w Index51.1 %
Show all parameters (20 more)
Stock CodeALKEM
Market Cap65,780 Cr.
Current Price5,502 ₹
Stock P/E29.4
Book Value1,171 ₹
Dividend Yield0.96 %
ROCE19.9 %
ROE18.2 %
Face Value2.00 ₹
Chg in FII Hold0.27 %
Chg in DII Hold1.25 %
PAT Qtr570 Cr.
PAT Prev Qtr294 Cr.
Volume2,37,457
Avg Vol 1Wk2,86,126
PEG Ratio1.05
Debt to equity0.04
Qtr Profit Var-6.60 %
EPS184 ₹
Industry PE34.8

🧾 Chart Verdict

Short-term entry zones could be established between 5,470 ₹ – 5,520 ₹, utilizing the current resistance level and momentum. A stop-loss order should be placed at 5,300 ₹ to mitigate downside risk. The bearish MACD trend suggests a potential reversal if the price breaks below 5,400 ₹. Overall, the stock exhibits mixed signals - maintain a cautious approach with an emphasis on monitoring volume and short-term support levels.

✅ Positive

The stock is currently trading above its 50-day moving average (DMA 50) at 5,375 ₹, suggesting a near-term bullish trend. Volume remains elevated relative to the weekly average, indicating strong buying interest.

⚠️ Limitation

Despite the positive momentum, the RSI of 53.4 is not yet in overbought territory, leaving room for further gains but also potential pullback risks. The MACD line remains deeply negative, signaling continued bearish pressure that may still prevail.

📈 Company Positive News

Recent news indicates a price increase and positive analysis from Univest, suggesting investor confidence and potentially more buying volume.

🏭 Industry

The pharmaceutical sector (Alkemet’s industry) is currently experiencing moderate growth driven by increasing demand for generic drugs and specialty medications. This is reflected in the relatively high Industry PE of 34.8, indicating market expectations for strong future earnings growth within this sector.

Choose Technical Analysis or Fundamental Analysis above to load it.

How ALKEM Rates Across All Strategies

★ 4.2
Entry Price: 5,470 ₹ – leveraging the current momentum and confirming…
★ 2.8
Buy at 5450 ₹ with a stop-loss at 5300 ₹.
★ 3.4
An entry price zone between 5,200 ₹ and 5,400 ₹ represents a reasonab…
Technical
★ 3.8
You're viewing this analysis below.
★ 2.8
Given the current valuation of 27.3x P/E compared to an industry aver…

NIFTY 50 · Technical

NEXT 50 · Technical

MIDCAP · Technical

SMALLCAP · Technical